Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

56.79 +1.05 (+1.88%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hologic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q3 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Rebounds, Oil Prices Drop To 7-Week Lows: What's Driving Markets Monday?
Wall Street opened higher at the start of a data-heavy week, with traders adopting an optimistic tone ahead of crucial earnings reports and economic events. 
Via Benzinga
Topics Economy
Exposures Interest Rates
$1000 Invested In Hologic 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Here's How Much $100 Invested In Hologic 20 Years Ago Would Be Worth Today
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Analyst Scoreboard: 7 Ratings For Hologic
Via Benzinga
Deep Dive Into Hologic Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation
Attorney Moze Cowper Wins Oral Argument Against Hologic Inc. in BioZorb Litigation 
Via News Direct
Topics Lawsuit
Exposures Financial Legal
Women's Health-Focused Hologic Has Significant Capacity For Expansion Via M&A, Bullish Analyst Says
Stephens initiated coverage on Hologic, highlighting its strong position in women's health and molecular diagnostics. Known for robust revenue growth and attractive profit margins, Hologic is set for... 
Via Benzinga
3 Online Sports Betting Stocks That Look Like Likely Winners
After billionaire Carl Icahn invested in Caesars, retail investors should also buy sports betting stocks. Here are three top names. 
Via InvestorPlace
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
HOLX Stock Earnings: Hologic Beats EPS, Beats Revenue for Q2 2024
HOLX stock results show that Hologic beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
The Analyst Landscape: 4 Takes On Hologic
Via Benzinga
Good technical signals and a possible breakout for HOLOGIC INC.
HOLOGIC INC is setting up nicely for a breakout. 
Via Chartmill
Analyst Ratings For Hologic
Via Benzinga
Based on good technical signals, HOLOGIC INC is potentially setting up for a breakout.
HOLOGIC INC is showing promising signs of setting up for a breakout. 
Via Chartmill
It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility
Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23. 
Via Talk Markets
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions. 
Via Benzinga
7 Mutual Funds That Will Outperform in Any Market
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
Via InvestorPlace
Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Recap: Hologic Q1 Earnings
Via Benzinga
Earnings Outlook For Hologic
Via Benzinga
Hologic Reports Better-Than-Expected Q1 Results
Hologic delivered strong revenue and profitability to start fiscal 2024, exceeding the high-end of our guidance for both the top-line and the bottom-line, says CEO. 
Via Benzinga
7 Mighty Healthcare Stocks Changing the Game of Medicine
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks. 
Via InvestorPlace
Biotech Playbook: Small Caps Show Momentum Peaking During
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market... 
Via Benzinga
Topics Stocks
Exposures US Equities
Small Caps Are On A Tear Including Speculative Biotechs
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. 
Via Talk Markets
Where Hologic Stands With Analysts
Via Benzinga
Earnings Scheduled For February 1, 2024
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
Hologic Stock Price Bounced Back: What's Next For HOLX?
Hologic share price jumped by over 11% from the lowest point in October. The company returned to post-COVID-19 growth as its key segments improved. The management expects that its business will... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.